LTT462
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LTT462, covering 2019-09-19 to 2019-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. [Phase 1]